5/A//SEC Filing
OxySure Therapeutics, Inc. 5/A
Accession 0001547522-16-000229
CIK 0001413797operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 1:13 PM ET
Size
5.8 KB
Accession
0001547522-16-000229
Insider Transaction Report
Form 5/AAmended
JONES JEREMY M
Director
Transactions
- Other
Common stock
2016-02-15$0.18/sh+50,000$9,250→ 364,292 total(indirect: By Trust)
Holdings
- 314,292(indirect: By Trust)
Common stock
Footnotes (1)
- [F1]Acquired as an incentive for extending the due date of certain payment obligations by the Company.
Documents
Issuer
OxySure Therapeutics, Inc.
CIK 0001413797
Entity typeoperating
Related Parties
1- filerCIK 0001413797
Filing Metadata
- Form type
- 5/A
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 1:13 PM ET
- Size
- 5.8 KB